Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03982511Not ApplicableCompleted

Improving Parent-Child Interactions to Enhance Child Health

Role: lead

NCT05165121Not ApplicableCompleted

Comparison of Hearing Aid Fitting Outcomes Between Self-fit and Professional Fit for MDHearing Smart Hearing Aids

Role: collaborator

NCT04501445Not ApplicableCompleted

Psychological Symptoms and Families of COVID-19 Patients

Role: collaborator

NCT01944657Not ApplicableWithdrawn

Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study

Role: collaborator

NCT01313325Not ApplicableCompleted

Hippotherapy to Improve the Balance of Children With Movement Disorders

Role: lead

All 5 trials loaded